≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback

Neuroendocrine tumor and carcinoma of stomach

Endpoint Browser PheWeb

C3_STOMACH_NEUROENDOCRINE

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

557745

1. Apply sex-specific rule

None

557745

2. Check conditions

None

557745

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Cancer registry: Topography ICD-O-3 — C16
  • Cancer registry: Morphology ICD-O-3 — 8240|824[2-4]|8246|8249
  • Cancer registry: Behaviour codes — 3

1 out of 7 registries used, show all original rules.

201

4. Check minimum number of events

None

201

5. Include endpoints

None

201

6. Filter based on genotype QC (FinnGen only)

181

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE

Extra metadata

First used in FinnGen datafreeze
DF9

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 181 99 82
Unadjusted period prevalence (%) 0.04 0.04 0.04
Median age at first event (years) 63.44 62.11 65.05

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
185
Matched controls
1850
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
K29.4
ICD-10 Finland
Chronic atrophic gastritis
157.7
197.9
101
14
B03BA03
ATC
hydroxocobalamin; parenteral
55.1
170.1
117
56
107
Kela drug reimbursment
Pernicious anaemia
119.3
155.2
81
12
D13.1
ICD-10 Finland
Benign neoplasm: Stomach
131.2
149.9
77
10
B81
ICPC
Anaemia vit B12/folate deficiency
45.2
134.3
90
38
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
26.1
83.8
161
378
8240/3-C16.9
ICD-O-3
Neuroendocrine tumor, NOS, of stomach, NOS
+∞
78.9
70
*
8240/3-C16.2
ICD-O-3
Neuroendocrine tumor, NOS, of body of stomach
+∞
69.2
62
*
D37.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Stomach
+∞
58.5
53
*
JDA05
NOMESCO Finland
Endoscopic polypectomy in stomach or pylorus
153.1
36.2
37
*
130
Kela drug reimbursment
Malignant tumour
+∞
34.5
32
*
WVA30, ,
SPAT
10.0
33.9
44
56
UJD02
NOMESCO Finland
Gastroscopy
7.9
23.5
36
55
C16.9
ICD-10 Finland
Malignant neoplasm: Stomach, unspecified
+∞
23.4
22
*
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
6.2
20.1
39
76
E34.0
ICD-10 Finland
Carcinoid syndrome
+∞
19.1
18
*
JN4AD
NOMESCO Finland
Body CT examination
6.3
16.8
31
57
H02AB02
ATC
dexamethasone; systemic
37.1
16.1
20
6
D51.0
ICD-10 Finland
Vitamin B12deficiency anaemia due to intrinsic factor deficiency
37.1
16.1
20
6
UJF32
NOMESCO Finland
Coloscopy
3.6
15.3
74
291
A50
ICPC
General and Unspecified, Medication/prescr/renewal
11.0
13.8
26
27
JN5ER
NOMESCO Finland
PET-CT of receptors in whole body
150.6
13.6
14
*
104
Kela drug reimbursment
Thyroid insufficiency
5.2
13.1
30
67
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
12.6
12
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
15.8
12.6
20
14
Z51.5
ICD-10 Finland
Palliative care
6.3
12.3
22
39
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
23.2
12.3
17
8
D64.9
ICD-10 Finland
Anaemia, unspecified
3.9
11.6
39
118
JDA45
NOMESCO Finland
Endoscopic mucosal or submucosal resection in stomach or pylorus
+∞
11.6
11
*
H03AA01
ATC
levothyroxine sodium; systemic
3.1
11.5
65
274
D51.9
ICD-10 Finland
Vitamin B12deficiency anaemia, unspecified
21.7
11.3
16
8
A55
ICPC
General and Unspecified, Local injection/infiltration
46.3
11.1
13
*
A03FA01
ATC
metoclopramide; systemic, rectal
3.6
11.1
42
138
K31.7
ICD-10 Finland
Polyp of stomach and duodenum
30.1
10.9
14
5
-50
ICPC
Medication/prescr/renewal
5.8
10.9
21
40
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
63.8
10.8
12
*
A04AA02
ATC
granisetron; systemic, transdermal
116.3
10.5
11
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
10.5
10
*
8240/3-C16.0
ICD-O-3
Neuroendocrine tumor, NOS, of cardia, NOS
+∞
10.5
10
*
TPH04
NOMESCO Finland
Cathetrisation of vein
3.0
10.0
55
226
103
Kela drug reimbursment
Diabetes, insulin-treated
2.7
9.9
79
396
WZC00
NOMESCO Finland
Treatment plan or consultation
2.8
9.7
65
297
JN4BD
NOMESCO Finland
Extensive body CT
5.3
9.6
20
41
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
9.5
9
*
8249/3-C16.2
ICD-O-3
Neuroendocrine tumor, grade 2 of body of stomach
+∞
9.5
9
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
9.5
9
*
XX3DW
NOMESCO Finland
Time consuming IT work
5.5
9.3
19
38
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
3.2
9.2
42
154
JN3AD
NOMESCO Finland
Abdominal CT examination
3.5
9.0
35
116
WVA20, ,
SPAT
8.3
8.9
19
25
215
Kela drug reimbursment
Diabetes, non-insulin-treated
2.7
8.8
68
332
H01CB02
ATC
octreotide; parenteral
94.2
8.5
9
*
8249/3-C16.9
ICD-O-3
Neuroendocrine tumor, grade 2 of stomach, NOS
+∞
8.4
8
*
L01BC06
ATC
capecitabine; oral
+∞
8.4
8
*
A10AB05
ATC
insulin aspart; parenteral
3.7
8.0
27
81
R4190
NOMESCO Finland
Nutritional therapy
10.1
7.9
15
16
A10AE04
ATC
insulin glargine; parenteral
3.3
7.7
31
105
B03BA02
ATC
cyanocobalamin tannin complex; parenteral
26.3
7.7
10
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.4
7.5
105
661
K31.8
ICD-10 Finland
Other specified diseases of stomach and duodenum
+∞
7.3
7
*
C16.09
ICD-10 Finland
Malignant tumor of cardiac or other unspecified carcinoma
+∞
7.3
7
*
C16.39
ICD-10 Finland
Malignant tumor of the antrum ventriculi other or unspecified carcinoma
+∞
7.3
7
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
+∞
7.3
7
*
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
2.4
7.3
70
373
S50
ICPC
Skin, Medication/prescr/renewal
31.4
7.2
9
*
XJD02
NOMESCO Finland
Peroral endoscopic ultrasonography
21.0
7.2
10
5
ZX114, ,
SPAT
11.6
6.9
12
11
SPAT1256
SPAT
Intramuscular and subcutaneous injection
2.3
6.8
90
547
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
41.6
6.8
8
*
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
41.6
6.8
8
*
A02BC02
ATC
pantoprazole; systemic
2.5
6.8
139
1014
WX408
NOMESCO Finland
General anesthesy, balanced
2.5
6.7
52
250
T90
ICPC
Diabetes non-insulin dependent
2.3
6.6
65
349
UGC12
NOMESCO Finland
Flexible bronchoscopy
4.0
6.5
19
51
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.6
6.5
22
66
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
72.2
6.5
7
*
8246/3-C16.0
ICD-O-3
Neuroendocrine carcinoma, NOS, of cardia, NOS
+∞
6.3
6
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
6.3
6
*
L02AE02
ATC
leuprorelin; implant, parenteral
+∞
6.3
6
*
C16.2
ICD-10 Finland
Malignant neoplasm: Body of stomach
+∞
6.3
6
*
B03BA01
ATC
cyanocobalamin; nasal, systemic
+∞
6.3
6
*
D13.3
ICD-10 Finland
Benign neoplasm: Other and unspecified parts of small intestine
+∞
6.3
6
*
C16.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of stomach
+∞
6.3
6
*
116
Kela drug reimbursment
Prostate cancer
+∞
6.3
6
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
6.3
6
*
H01CB03
ATC
lanreotide; parenteral
+∞
6.3
6
*
C16.00
ICD-10 Finland
Cardia
+∞
6.3
6
*
A10BA02
ATC
metformin; oral
2.2
6.2
73
420

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
77
34
38.08
111.87
2.2
1.3
—
—
—
0
0
112
231
10.75
60.75
3.3
1.2
—
—
—
0
0
32
0
+∞
34.45
2.7
0.0
253.29
—
pmol/l
—
23
0
47
95
6.29
23.55
2.8
1.4
14.23
2.63
ug/l
1.24
37
71
92
427
3.30
14.35
3.5
2.3
3.25
2.94
mg/l
0.57
84
359
63
236
3.53
13.84
2.5
2.3
2.42
2.26
g/l
1.08
57
215
122
689
3.26
13.27
5.8
3.4
34.41
35.65
g/l
1.55
112
639
63
258
3.19
11.74
2.8
2.4
11.86
12.48
umol/l
0.14
56
236
77
364
2.91
11.02
2.6
1.8
585.97
426.46
pmol/l
1.37
59
301
127
799
2.88
10.25
8.0
3.7
10.55
12.13
umol/l
1.55
120
749
123
762
2.83
10.21
11.6
14.5
1.16
1.28
inr
2.09
106
620
114
682
2.75
10.09
5.1
3.0
85.08
112.87
ug/l
0.80
104
628
125
812
2.66
8.93
10.7
5.8
4.52
4.30
e9/l
0.39
107
692
121
779
2.60
8.72
3.3
2.1
83.33
95.75
pmol/l
2.03
78
383
8
0
+∞
8.39
2.8
0.0
56.74
—
pmol/l
—
8
0
119
776
2.50
8.10
6.9
5.4
1.63
1.85
e9/l
2.78
106
668
87
494
2.44
8.05
7.1
5.0
—
—
—
0
0
40
154
3.04
8.03
1.4
1.2
—
—
—
0
0
88
506
2.41
7.88
1.9
1.7
25.39
20.62
nmol/l
1.71
81
415
88
515
2.35
7.47
3.4
2.2
54.48
68.09
u/l
0.78
81
472
107
682
2.35
7.43
7.5
5.4
2.74
3.04
%
0.65
102
628
32
114
3.18
7.29
1.3
1.1
—
—
—
0
0
114
761
2.30
6.91
7.0
5.4
0.60
0.58
e9/l
0.38
99
638
118
803
2.30
6.78
7.2
6.0
1.21
1.21
mmol/l
0.06
99
686
100
640
2.22
6.62
2.7
2.4
—
—
estimate
—
0
0
114
770
2.25
6.60
7.0
5.3
0.04
0.04
e9/l
0.02
99
647
78
453
2.25
6.54
2.8
2.1
—
—
—
0
0
116
792
2.25
6.50
7.3
5.4
0.19
0.20
e9/l
0.27
100
675
39
170
2.64
6.14
2.7
2.1
9.09
5.74
umol/l
0.52
32
149
18
49
3.96
6.09
1.3
1.2
281.56
307.90
ug/g
—
9
27
58
311
2.26
5.79
2.1
1.7
1084.62
1224.52
nmol/l
0.63
42
232
105
714
2.09
5.64
6.9
5.6
1.21
1.21
mmol/l
0.05
99
636
78
479
2.09
5.47
4.1
3.3
7.40
7.40
ph
0.13
61
324
31
128
2.71
5.40
1.2
1.4
—
—
—
0
0
148
1168
2.34
5.16
12.2
5.6
92.84
77.26
u/l
1.77
143
1087
68
405
2.07
5.11
4.6
3.7
—
—
—
0
0
77
481
2.03
5.08
2.2
1.6
—
—
—
0
0
41
201
2.34
4.98
2.0
1.9
1.74
1.66
%
0.22
35
176
7
5
14.47
4.61
1.0
1.6
—
—
—
0
0
27
119
2.49
4.11
1.2
1.6
—
—
—
0
0
65
412
1.89
3.92
2.4
2.4
343.23
354.60
umol/l
0.37
52
359
8
11
7.54
3.90
1.1
1.3
14.63
25.78
ng/l
—
8
11
51
301
1.96
3.79
1.4
1.3
3.04
2.75
g/l
0.31
34
177
24
108
2.40
3.50
5.6
4.5
0.00
0.09
%
—
5
22
73
499
1.76
3.36
3.8
3.4
—
—
—
0
0
53
331
1.84
3.28
1.5
1.8
1.28
1.22
mg/l
0.04
38
266
23
105
2.36
3.25
5.0
4.4
0.20
0.21
%
—
5
24
24
113
2.29
3.17
5.6
4.4
0.20
0.72
%
—
5
27
85
621
1.68
3.00
5.2
4.0
41.61
6.94
mg/mmol
0.51
52
374
84
614
1.67
2.95
4.4
3.2
6.05
7.43
mmol/l
3.30
66
515
30
162
2.02
2.83
1.8
2.0
72.59
64.10
e9/l
0.66
21
122
35
200
1.93
2.82
1.3
1.4
196.67
564.44
titre
2.57
12
54
65
449
1.69
2.79
4.0
2.9
1.87
0.47
e6/l
0.99
49
315
47
300
1.76
2.66
1.3
1.3
12.73
40.85
iu/ml
2.88
14
93
7
15
4.80
2.62
2.1
1.7
2.74
249.14
u/ml
—
7
15
81
601
1.62
2.60
4.5
3.3
38.27
40.44
mg/l
0.04
54
370
6
11
5.59
2.56
1.0
1.4
—
—
—
0
0
6
11
5.59
2.56
3.3
3.2
—
—
—
0
0
16
70
2.41
2.49
1.1
1.3
—
—
—
0
0
16
70
2.41
2.49
3.9
4.1
—
—
—
0
0
52
350
1.68
2.42
1.3
1.3
—
—
—
0
0
13
52
2.61
2.41
1.2
1.0
—
—
—
0
0
86
657
1.58
2.39
14.7
10.2
0.00
0.00
e9/l
0.53
72
525
59
413
1.63
2.36
4.3
2.9
—
0.00
estimate
—
0
7
27
151
1.92
2.31
3.3
1.8
28.18
37.19
u/l
0.66
22
121
105
847
1.55
2.26
5.1
4.0
0.00
0.00
estimate
-0.00
21
164
106
857
1.55
2.26
5.3
4.0
0.00
0.03
estimate
0.50
21
154
23
123
1.99
2.23
2.5
2.6
1.22
1.23
mmol/l
0.48
23
103
104
839
1.55
2.22
5.0
3.9
0.00
0.00
estimate
-0.00
22
164
77
582
1.55
2.20
5.8
3.8
319.96
110.06
e6/l
0.32
55
401
27
156
1.86
2.11
1.3
1.6
—
—
—
0
0
26
149
1.87
2.08
4.0
3.4
7.35
7.33
ph
0.09
20
95
30
181
1.78
2.04
2.6
1.7
—
—
—
0
0
51
356
1.60
2.03
1.4
1.3
0.74
1.48
u/ml
0.75
12
105
21
113
1.97
2.01
1.6
1.3
—
—
—
0
0
49
340
1.60
2.00
3.6
2.2
2.45
2.44
mmol/l
0.02
43
292
138
1201
1.59
1.98
7.0
4.1
15.22
14.97
pmol/l
0.53
127
1085
20
108
1.96
1.90
4.5
3.9
—
—
—
0
0
69
525
1.50
1.86
4.8
3.0
507.79
168.24
e6/l
0.32
53
393
46
323
1.56
1.78
6.1
4.2
85.58
251.30
ng/l
0.93
38
268
6
18
3.41
1.76
5.5
3.1
—
—
—
0
0
46
324
1.56
1.75
6.5
4.5
—
—
—
0
0
35
231
1.64
1.74
1.6
1.7
28.89
28.88
s
0.00
35
225
23
135
1.80
1.72
4.7
8.7
—
—
—
0
0
39
267
1.58
1.67
1.3
1.3
1.23
16.42
u/ml
2.33
15
97
10
41
2.52
1.67
1.7
1.6
—
—
—
0
0
50
364
1.51
1.64
2.6
2.2
5.32
4.50
e6/l
0.28
41
327
43
303
1.55
1.63
2.7
2.9
573.28
523.44
mosm/kgh2o
0.94
36
256
29
186
1.66
1.61
1.7
1.5
—
—
—
0
0
11
52
2.19
1.47
3.5
4.8
24.58
26.00
mmol/l
1.73
11
46
83
678
1.41
1.47
4.0
3.4
6.28
6.23
ph
0.15
47
376
25
158
1.67
1.47
2.8
3.0
4.43
4.40
kpa
0.02
25
153
58
446
1.44
1.43
4.3
3.4
0.00
0.00
estimate
-0.00
19
127
9
41
2.26
1.39
1.1
1.1
—
—
—
0
0
32
219
1.56
1.38
2.5
1.9
—
—
—
0
0
22
137
1.69
1.37
2.2
1.5
—
—
—
0
0
5
17
2.99
1.36
1.2
1.0
—
—
—
0
0
0
38
0.00
1.36
0.0
1.2
—
—
—
0
0
0
38
0.00
1.36
0.0
1.3
—
3.10
—
0
31
0
39
0.00
1.35
0.0
1.4
—
212.78
—
0
32
13
69
1.95
1.32
1.2
1.4
—
—
—
0
0
17
100
1.77
1.28
2.1
2.5
—
—
—
0
0
6
25
2.45
1.25
1.2
2.5
—
—
—
0
0
10
49
2.10
1.24
1.9
1.6
—
—
—
0
0
86
722
1.36
1.24
3.7
4.0
151.05
40.56
ng/l
0.44
69
540
18
109
1.72
1.24
1.1
1.3
—
—
—
0
0
159
1480
1.53
1.19
25.9
14.3
28.16
22.86
mg/l
1.05
147
1185
28
194
1.52
1.15
3.1
3.3
7.39
7.39
ph
0.21
16
114
59
472
1.37
1.14
5.6
4.0
0.00
0.00
estimate
-0.00
20
150
8
41
1.99
1.10
1.9
3.3
7.42
7.42
ph
—
8
41
5
22
2.31
1.04
3.8
2.0
10.80
10.36
mmol/l
—
5
22
17
107
1.65
1.04
1.9
2.4
0.55
0.62
%
0.56
17
107
15
92
1.69
1.00
4.7
9.6
24.88
24.97
mmol/l
0.04
15
92
5
23
2.21
0.98
1.2
1.9
—
—
—
0
0
21
143
1.53
0.95
1.5
1.5
—
—
—
0
0
15
94
1.65
0.94
1.9
1.2
335.67
98.31
u/ml
—
6
41
76
648
1.29
0.92
4.8
3.9
0.15
0.00
estimate
0.48
20
133
33
252
1.38
0.84
6.1
3.1
2.12
2.63
e6/l
0.17
17
109
6
32
1.90
0.82
1.0
1.1
—
—
—
0
0
152
1433
1.34
0.77
8.4
5.2
1.99
1.95
mu/l
0.13
141
1293
10
59
1.73
0.77
1.2
1.3
—
—
—
0
0
0
28
0.00
0.76
0.0
1.1
—
—
—
0
0
16
108
1.53
0.76
1.9
2.4
1.09
1.24
%
0.43
16
108
5
24
2.11
0.75
1.8
1.4
—
—
—
0
0
10
60
1.70
0.73
1.1
1.3
—
1.88
—
0
5
25
187
1.39
0.73
5.0
6.9
-0.08
1.20
mmol/l
0.90
17
154
14
93
1.55
0.72
3.5
4.2
—
—
—
0
0
5
26
1.95
0.71
1.0
1.0
—
—
—
0
0
5
27
1.87
0.69
2.0
3.6
8.72
8.51
kpa
—
5
27
5
27
1.87
0.69
2.0
3.6
5.02
4.99
kpa
—
5
27
25
192
1.35
0.63
5.1
6.8
7.41
7.42
ph
—
10
112
18
137
1.35
0.49
4.2
2.8
6.23
6.02
ph
0.53
13
93
11
76
1.48
0.49
1.2
1.3
—
—
—
0
0
51
445
1.20
0.48
4.8
4.2
—
—
—
0
0
7
47
1.51
0.48
1.6
1.4
—
—
—
0
0
13
94
1.41
0.47
1.2
1.4
—
—
—
0
0
14
104
1.37
0.44
2.9
3.2
23.79
24.40
mmol/l
0.28
14
104
0
17
0.00
0.41
0.0
1.2
—
—
—
0
0
11
80
1.40
0.39
2.1
3.1
4.12
4.38
pmol/l
0.32
11
70
0
19
0.00
0.39
0.0
1.0
—
380.23
—
0
13
51
566
0.86
0.36
3.7
3.8
—
—
—
0
0
161
1566
1.22
0.35
31.1
17.9
139.17
139.90
mmol/l
3.04
161
1521
6
44
1.38
0.35
1.0
1.2
—
—
—
0
0
6
44
1.38
0.35
1.2
1.9
2.09
1.56
mg/l
—
6
38
153
1482
1.19
0.34
10.6
7.1
43.33
40.27
mmol/mol
2.86
143
1381
140
1449
0.86
0.34
5.1
4.6
1.31
1.27
mmol/l
0.31
122
1309
161
1567
1.21
0.33
31.3
18.0
3.97
4.00
mmol/l
0.78
161
1517
36
320
1.16
0.28
3.2
3.1
0.77
0.76
ug/l
0.02
30
204
14
113
1.26
0.27
1.4
1.2
—
—
—
0
0
6
85
0.70
0.24
3.5
4.3
37.02
36.95
°c
—
6
85
5
37
1.36
0.23
1.0
1.2
—
—
—
0
0
5
38
1.32
0.23
1.4
1.3
61.60
66.33
mmol/l
—
5
30
13
107
1.23
0.22
1.2
1.4
—
45.88
—
0
10
0
10
0.00
0.21
0.0
1.2
—
189.89
—
0
10
0
10
0.00
0.21
0.0
4.4
—
—
—
0
0
72
680
1.10
0.21
2.2
1.9
1.41
1.30
mmol/l
0.33
61
573
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
154
1510
1.12
0.18
7.5
5.5
6.54
6.06
mmol/l
2.37
147
1363
7
62
1.13
0.17
1.0
1.1
—
—
—
0
0
5
66
0.75
0.17
20.8
7.0
—
—
—
0
0
20
178
1.14
0.16
2.1
2.5
2.46
7.94
ug/l
2.68
15
152
10
85
1.19
0.12
1.4
1.4
—
—
—
0
0
121
1235
0.94
0.11
35.8
18.5
327.57
331.27
g/l
3.15
121
1230
148
1501
0.93
0.11
6.2
5.5
1.39
1.49
mmol/l
2.02
133
1376
149
1510
0.93
0.10
6.2
5.6
4.19
4.57
mmol/l
3.92
135
1391
151
1529
0.93
0.10
7.4
6.5
2.32
2.63
mmol/l
3.86
137
1404
15
137
1.10
0.07
4.6
2.3
0.10
0.52
e6/l
1.72
15
125
161
1596
1.07
0.06
35.4
19.3
80.61
79.31
umol/l
0.19
161
1564
40
385
1.05
0.06
5.0
4.0
1.02
1.02
kg/l
0.19
29
249
53
542
0.97
0.04
5.5
4.5
5.53
2.03
ug/l
0.60
48
482
155
1543
1.03
0.01
22.3
13.1
—
—
—
0
0
161
1614
0.98
0.00
41.3
21.6
29.67
30.37
pg
4.13
161
1588
161
1614
0.98
0.00
41.9
22.2
38.89
40.42
%
3.25
161
1588
161
1613
0.99
0.00
41.4
21.7
90.19
91.50
fl
2.74
161
1587
161
1615
0.98
0.00
41.8
21.8
128.45
135.28
g/l
6.84
161
1587
0
5
0.00
0.00
0.0
9.6
—
0.72
—
0
5
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
0.00
0.0
1.1
—
1.74
—
0
9
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.6
—
2700.00
—
0
5
0
5
0.00
0.00
0.0
5.2
—
6.70
—
0
5
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
8
81
0.99
-0.00
2.3
1.8
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
11.4
—
1060.00
—
0
7
0
6
0.00
-0.00
0.0
1.0
—
1920.00
—
0
6
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: C3_STOMACH_NEUROENDOCRINE – Neuroendocrine tumor and carcinoma of stomach

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).